Making fun of the headlines today, so you don’t have to
The news, even that about pilots on magic mushrooms, doesn’t need to be complicated or confusing; that’s what any new release from Microsoft is for. And, as in the case with anything from Microsoft, to keep the news from worrying our pretty little heads over, remember something new and equally indecipherable will come out soon:
Really all you need to do is follow one simple rule: barely pay attention and jump to conclusions. So, here are some headlines today and my first thoughts:
Flying high on magic mushrooms.
The pilot on Alaskan Airways flight that shut down the engines was on magic mushrooms
I’m shocked, shocked he could get anything to eat on a flight.
‘Cursed’ Ted Cruz shows up at Astros game and you can guess what happened
Would’ve gotten away with it, but they came back for a free refill.
President Biden calls for assault weapon ban and other measures to curb gun violence
Hey, we should at least change its name from an AR-15 to an AR-19, so Matt Gaetz won’t be interested it in.
Pennsylvania trio bought a $100K abandoned school and turned it into a packed 31-unit apartment complex
Instead of eviction, they’re sent to detention …
Britney Spears reveals she lived in Orlando with Justin Timberlake in the early 2000s
George Santos: Me, too.
Taylor Swift to be joined by Travis Kelce during the international leg of her ‘Eras’ tour
Wondering, if Taylor Swift did a tour of only songs about old boyfriends, would it be called the ‘Errors’ tour?
RIP Richard Roundtree
They say this cat Shaft is a bad mother. Shut your mouth. God speed.
‘Sponge bombs’ are Israel’s new secret weapon to block Hamas tunnels
That would certainly be ‘sponge’ worthy …
Iceland’s prime minister joins thousands of women on strike
Now, that’s cold …
Larry Elder drops out of the race for President
… Surprising people that he was in the race for President.
Only 2 of the 8 House Speaker candidates voted to certify Biden’s win
The others were just certifiable.
Bulldog ‘thinks she’s a cow’ and the video evidence is priceless
Owners decide not to tell her because they need the milk.
Trump claims he doesn’t know who gave Fauci presidential award. It was him
… Trump: I never met me. Maybe I got myself coffee once. And, besides, I never liked me anyway …
Paul Lander is not sure which he is proudest of — winning the Noble Peace Prize or sending Congolese gynecologist Dr. Denis Mukwege to accept it on his behalf, bringing to light the plight of African women in war-torn countries. In his non-daydreaming hours, Paul has written for Weekly Humorist, National Lampoon, American Bystander, Huff Post Comedy, McSweeney’s, Bombeck Writers Workshop Blog and the Humor Times, written and/or produced for multiple TV shows and written standup material that’s been performed on Maher, The Daily Show, Colbert, Kimmel, etc. Now, on to Paul’s time-commanding Special Forces in Khandahar… (See all of Paul’s “Ripping the Headlines Today” columns here.)
The COVID-19 pandemic is definitively over, according to two recent reports focused on the same metric.
That metric is excess deaths, a measure of the difference between the number of deaths that occurred through the pandemic years, beginning in March 2020, and the number that would be expected in a nonpandemic year, based on data from earlier years.
Jan. 30, 2023 – When he was a young boy growing up in Brooklyn, Anthony Fauci loved playing sports. As captain of his high school basketball team, he wanted to be an athlete, but at 5-foot-7, he says it wasn’t in the cards. So, he decided to become a doctor instead.
Fauci, who turned 82 in December, stepped down as the head of the National Institute of Allergy and Infectious Diseases that same month, leaving behind a high-profile career in government spanning more than half a century, during which he counseled seven presidents, including Joe Biden. Fauci worked at the National Institutes of Health for 54 years and served as director of the National Institute of Allergy and Infectious Diseases for 38 years. In an interview last week, he spoke to WebMD about his career and his plans for the future.
This interview has been edited and condensed.
It’s only been a few weeks since your official “retirement,” but what’s next for you?
What’s next for me is certainly not classical retirement. I have probably a few more years of being as active, vigorous, passionate about my field of public health, public service in the arena of infectious diseases and immunology. [I’ve] had the privilege of advising seven presidents of the United States in areas that are fundamentally centered around our response and preparation for emerging infections going back to the early years of HIV, pandemic flu, bird flu, Ebola, Zika, and now, most recently the last 3 years, with COVID. What I want to do in the next few years, by writing, by lecturing, and by serving in a senior advisory role, is to hopefully inspire young people to go into the field of medicine and science, and perhaps even to consider going into the area of public service.
Almost certainly, I’ll begin working on a memoir. So that’s what I’d like to do over the next few years.
Are you looking forward to going back and seeing patients and being out of the public eye?
I will almost certainly associate myself with a medical center, either one locally here in the Washington, DC, area or some of the other medical centers that have expressed an interest in my joining the faculty. I am not going to dissociate myself from clinical medicine, since clinical medicine is such an important part of my identity and has been thus literally for well over 50 years. So, I’m not exactly sure of the venue in which I will do that, but I certainly will have some connection with clinical medicine.
What are you looking forward to most about going back to doctoring?
Well, I’ve always had a great deal of attraction to the concept of medicine, the application of medicine. I have taken care of thousands of patients in my long career. I spent a considerable amount of time in the early years of HIV, even before we knew it was HIV, taking care of desperately ill patients. I’ve been involved in a number of clinical research projects, and I was always fascinated by that because there’s much gratification and good feeling you get when you take care of, personally, an individual patient, when you do research that advances the field, and those advances that you may have been a part of benefit larger numbers of patients that are being taken care of by other physicians throughout the country and perhaps even throughout the world.
So those are all of the aspects of clinical medicine that I want to encourage younger people that these are the opportunities that they can be a part of, which can be very gratifying and certainly productive in the sense of saving lives.
Looking back over your career, what were some of the highs and lows, or turning points?
I first became involved in the personal care and research on persons with HIV, literally in the fall of 1981. [That was] weeks to months after the first cases were recognized. My colleagues and I spent the next few years taking care of desperately ill patients, and we did not have effective therapies because the first couple of years, we did not even know what the ideologic agent was. Even after it was recognized after 1983 and 1984, it took several years before effective therapies were developed, so there was a period of time where we were in a very difficult situation. We were essentially putting Band-Aids on hemorrhages, metaphorically, because no matter what we did, our patients continued to decline. That was a low and dark period of our lives, inspired only by the bravery and the resilience of our patients. A very high period was in [the late 1990s] and into the next century [with the development] of drugs that were highly effective in prolonged and effective suppression of viral loads to the point where people who were living with HIV, if they had access to therapy, could essentially lead a normal lifespan..
We put together the President’s Emergency Plan for AIDS Relief program know as PEPFAR, which now, celebrating its 20th anniversary, has resulted in saving 20-25 million lives. So, I would say that is … the highest point in my experience as a physician and a scientist, to have been an important part in the development of that program.
Do you feel like there’s any unfinished business? Anything you would change?
Certainly, there’s unfinished business. One of the goals I would have liked to have achieved, but that is going to have to wait another few years, is the development of a safe and effective vaccine for HIV. A lot of very elegant science has been done in that regard, but we’re not there yet, it’s a very challenging scientific problem.
The other unfinished business is some of the other diseases that cause a considerable amount of morbidity and mortality globally, diseases like malaria and tuberculosis. We’ve made extraordinary progress over the 38 years that I’ve been director of the institute We have a vaccine, though it isn’t a perfect vaccine [for malaria]; we have monoclonal antibodies that are now highly effective in preventing malaria; we have newer drugs, better drugs for tuberculosis, but we don’t have an effective vaccine for tuberculosis. So, malaria vaccines, tuberculosis vaccines, those are all unfinished business. I believe we will get there.
These new COVID-19 variants keep getting more and more contagious. Do you see the potential for a serious new variant that could plunge us back into some level of public restrictions?
Anything is possible. One cannot predict, exactly, what the likelihood of getting yet again another variant that’s so different that it eludes the protection that we have from the vaccines and from prior infection. Again, I can’t give a number on that. I don’t think it’s highly likely that will happen.
Ever since Omicron came well over a year ago, we have had sublineages of Omicron that progressively seem to elude the immune response that’s been developed. But the one thing that’s good and has been sustained is that protection against severity of disease seems to hold out pretty well. I don’t think that we should be talking about restrictions in the sense of draconian methods of shutting things down; I mean, that was only done for a very brief period of time when our hospitals were being overrun. I don’t anticipate that that is going to be something in the future, but you’ve got to be prepared for it. There are some things that have been highly successful, and that is the vaccines that were developed in less than 1 year. And now, our challenge is to get more people to get their updated boosters.
There’s already been criticism of the FDA’s discussion about of an annual COVID-19 vaccine. One criticism is that the COVID vaccines’ effectiveness appears to wane after several months, so it would not offer protection for much of the year. Is that a legitimate criticism?
There’s no perfect solution to keeping the country optimally protected. I believe that it gets down to, “It’s not perfect, but don’t let the perfect be the enemy of the good.” We want to get into some regular cadence to get people updated with a booster that is hopefully managed reasonably well to what the circulating variant is. There are certainly going to be people – perhaps the elderly, some of the immune-compromised, and perhaps children – who will need a shot more than once per year, but the FDA’s leaning towards getting a shot that is [timed] with the flu shot, would at least bring some degree of order and stability to the process of people getting into the regular routine of keeping themselves updated and protected to the best extent possible.
Do you think we need to move on from mRNA vaccines to something that hopefully has longer-lasting protection?
Yes, we certainly want next-generation vaccines – both vaccines that have a greater degree of breadth, namely covering multiple variants, as well as a greater degree of duration. So, the real question is, “Is it the mRNA vaccine platform that is inducing a response that is not durable, or is the response against coronaviruses not a durable response?” That’s still uncertain. Yes, we need to do better with a better platform, or an improvement on the platform; that could mean adding adjuvants, that could mean a [nasal] vaccine in addition to a systemic vaccine.
Do you always wear a mask when you go out into the world? How do you evaluate the relative risk of situations when you go out in public?
I’ve been vaccinated, doubly boosted, I’ve gotten infected, and I’ve gotten the bivalent boost. So, I evaluate things depending upon what the level of viral activity is in the particular location where I’m at. If I’m going to go on a plane, for example, I have no idea where these people are coming from, I generally wear a mask on a plane. I don’t really go to congregate settings often. Many of the events I do go to are situations where a requirement for [attending] is to get a test that’s negative that day.
When you’re in a situation like that, even if it’s a crowded congregant setting, I don’t have any problem not wearing a mask. But when I’m unsure of what the status is and I might be in an area where there is a considerable degree of viral activity, I would wear a mask. I think you just have to use [your] judgment, depending on the circumstances that you find yourself in.
Doctors and health care professionals have been through hell during COVID. Do you think this might bring a permanent change to how doctors perceive their jobs?
Health care providers have been under a considerable amount of stress because this is a totally unprecedented situation that we find ourselves in. This is the likes of which we have not seen in well over 100 years. I hope this is not something that is going to be permanent, I don’t think it is, I think that we are ultimately going to get to a point where the level of virus is low enough that it’s not going to disrupt either society or the health care system or the economy.
We’re not totally there yet. We’re still having about 500 deaths per day, which is much, much better than the 3,000 to 4,000 deaths that we were seeing over a year ago, but it is still not low enough to be able to feel comfortable.
As a scientist, even a semi-retired one, what scares you? What wakes you up at night with worry?
The same thing I have been concerned about for, you know, 40 years: the appearance of a highly transmissible respiratory virus that has a degree of morbidity and mortality that could really be very disruptive of us in this country and globally. Unfortunately, we’re in the middle of that situation now, finishing our third year and going into year 4. So what worries me is yet another pandemic. Now that could be a year from now, 5 years from now, 50 years from now. Remember, the last time a pandemic of this magnitude occurred was well over 100 years ago. My concern is that we stay prepared. [We may] not necessarily prevent the emergence of a new infection, but hopefully we can prevent it from becoming a pandemic.
Nov. 22, 2022 – White House officials on Friday urged Americans – again – to get their COVID-19 vaccines and boosters, as the latest booster shot has a better immune response to the evolving COVID-19 variants BA.4 and BA.5.
“Recent data that has come out indicate that, in fact, if you are vaccinated and boosted, compared to an unvaccinated person, there is a 14 times lower risk of dying in the most recent BA.4-5 era, compared to unvaccinated, and at least a three times lower risk of testing positive, compared to unvaccinated individuals,” said Anthony Fauci, MD, who stood at the White House press briefing podium “one last time” as he bid farewell to reporters on Tuesday.
The physician-scientist will be stepping down from his position as director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden next month.
Fauci has made it clear that he is not retiring, but rather, pursuing “the next chapter” of his career.During his more than 5 decades of service to the federal government, he has spearheaded the fights against HIV and AIDS, Ebola, and COVID-19, among other health crises.
White House COVID-19 Response Coordinator Ashish Jha, MD, joined Fauci on the podium and highlighted the latest developments in COVID-19 vaccinations and disease prevention.
On Monday, 12 of America’s top medical and clinical societies, including the American Medical Association and the American College of Physicians, released a statement with a clear message: Go get your updated COVID-19 vaccine and annual flu shot, which is the best way to save lives this holiday season – particularly the lives of older Americans.
Other announcements included a “6-week sprint” to help Americans get their updated COVID shot by the end of December. Three hundred and fifty million dollars in funding will go towardcommunity health centers, mobile vaccine clinics, and religious organizations to assist in vaccine education and distribution. There will also be $125 million in funding for aging and disability networks to get more vulnerable and disabled Americans vaccinated.
Jha also said that most Americans will need one shot each year to stay safe, similar to the flu shot.
“We need to make protecting our loved ones an important part of the conversation we have around the Thanksgiving table and an important part of the conversation that we have in the days and weeks ahead,” he said.
“If folks get their updated vaccines, and they get treated if they have a breakthrough infection, we can prevent essentially every COVID death in America.”
For more information on COVID-19 vaccines, click here.
The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S., accounting for 11.4% of new cases across the nation in the week ending Oct. 15.
The two variants are lineages of BA.5, the omicron subvariant that remains dominant but has shrunk to account for just 67.9% of circulating variants, the agency said in a Friday update. The CDC had previously combined BQ.1 and BQ.1.1 with BA.5 cases because the numbers of the new variants were so small. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places.
New York and New Jersey currently have the highest proportion of BQ.1 and BQ.1.1 infections, at about 20% of overall cases, according to CDC estimates.
“When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” Anthony Fauci, President Joe Biden’s chief medical adviser, said in an interview with CBS News.
Adding to concerns, the variant seems “to elude important monoclonal antibodies,” he added.
Fauci is confident that Moderna MRNA, +3.92%,
as well as Pfizer PFE, +1.84%
and German partner BioNTech BNTX, +2.45%,
will be able to update boosters to target the new subvariant. “The somewhat encouraging news is that it’s a BA.5 sublineage, so there are almost certainly going to be some cross-protections that you can boost up,” he said.
So far, only 14.8 million people living in the U.S. have taken advantage of the new bivalent boosters that were authorized by the Food and Drug Administration in late August. That’s equal to about 7% of the 209 million who were initially eligible.
The FDA authorized the Pfizer booster for use in people aged 12 and older and the Moderna booster for adults aged 18 and older. Last week, the FDA added children aged 5 to 11 to the Pfizer program and children aged 6 through 17 to the Moderna one.
Experts are concerned that the low number of vaccinations is due to a sense that the pandemic is over and no longer poses a major risk for most people. U.S. cases are steadily declining and now stand at their lowest level since mid-April; however, the true tally is likely higher than the official count, because many people are testing at home, where data are not being collected.
The daily average for new cases stood at 37,649 on Sunday, down 19% from two weeks ago, according to a New York Times tracker.
The daily average for hospitalizations was down 5% to 26,475, while the daily average for deaths was down 8% to 374.
But cold weather is expected to bring a new wave of cases, and hospitalizations are rising again in much of the Northeast, the Times tracker is showing.
“That’s the thing that’s so frustrating for me and for my colleagues who are involved in this, is that we have the capability of mitigating against this. And the uptake of the new bivalent vaccine is not nearly as high as we would like it to be,” said Fauci.
• Moderna and Gavi, the Vaccine Alliance, which is supplying vaccines to low- and middle-income countries, have agreed to cancel remaining orders under their 2022 COVID-19 vaccine agreement given “sufficient supply.” The biotechnology company has supplied Gavi with nearly 70 million doses of COVID-19 vaccines, in addition to facilitating the donation of more than 100 million doses. Moderna and Gavi said they will create a new framework that enables Gavi to buy up to 100 million COVID-19 vaccine doses in 2023.
• The World Health Organization, the Food and Agriculture Organization of the United Nations, the United Nations Environment Program and the World Organization for Animal Health on Monday launched a new initiative that aims to address health threats to humans, animals, plants and the environment. The One Health Joint Plan of Action “aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats,” the four agencies said in a statement.
• China is doubling down on its zero-COVID strategy as a historic Communist Party congress opens in Beijing, BBC News reported. Zero COVID was a “people’s war to stop the spread of the virus,” said President Xi Jinping as he kicked off the meeting. There is increasing public fatigue over lockdowns and travel restrictions, and Beijing has come under strict security measures ahead of the congress, sparking frustration in the city, including a rare and dramatic public protest on Thursday criticizing Xi and his strategy.
In a rare display of defiance, two banners were unfurled from a highway overpass in Beijing condemning Chinese President Xi Jinping and his strict COVID-19 policies. The protest took place days before the expected extension of Xi’s tenure.
• Airline stocks rallied Monday after data showed that on Sunday, more people flew than on any other day since before the pandemic. Data from the Transportation Security Administration showed that 2.495 million travelers went through TSA checkpoints on Sunday, which is just above the previous 2022 high of 2.490 million on July 1 and the most since Feb. 11, 2020, which was exactly one month before the World Health Organization declared COVID-19 a global pandemic. In comparison, the day with the fewest travelers since the start of the pandemic was April 12, 2022, with 87,534 people traveling. And in 2019, there were 116 days of more travelers than Sunday, while the average for that year was 2.306 million. The U.S. Global Jets ETF JETS, +2.02%
was up 2.2%.
The U.S. leads the world with 96.9 million cases and 1,065,118 fatalities.
The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.
Oct. 5, 2022 – Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to President Joe Biden, said this week that he isn’t ready to say that we are nearing the end of COVID-19. But as a country, we seem to be on the right track, Fauci said during a virtual conversation for the University of Southern California’s Annenberg’s Center for Health Journalism.
This comes just 2 weeks after Biden said that “the pandemic is over” on CBS’s 60 Minutes. Last month, the World Health Organization also said the end of COVID is in sight.
“It’s obvious that [the president’s statement] could be problematic because people would interpret it as ‘it’s completely over and we’re done for good,’ which is not the case, no doubt about that,” Fauci said.
Instead, he interpreted the comment as a reference to the country’s improvement in case numbers and death rates over the last several months — that the worst is likely behind us.
Fauci, who has been the subject of harsh criticism for his public messaging, chooses his words carefully, even with the promise of a brighter future ahead.
“I think it would be cavalier to all of the sudden say we’re through with [COVID],” he said. “Because remember, we were going in the right direction in the summer of 2021, and along came Delta. Then in the winter, along came Omicron. And since then, we’ve had sublineages of Omicron.”
Especially as the winter months approach, Fauci said, precautions still need to be taken to reduce the chances of yet another spike. When asked about the precautions that he himself takes, Fauci explained that he still doesn’t go to indoor, sit-down dinners. He continues to attend receptions — noting that most of them are outdoors — without a mask on, but if he’s in an indoor setting “for a considerable period of time,” he keeps a mask on.
A large portion of the conversation also reflected on the lessons that can be learned from mixed messages delivered by public health experts, including Fauci, during both the COVID pandemic and the more recent developments in monkeypox.
“I have tried always to give the hard truth, but very often the hard truth is not heard under the circumstance under which it’s given,” Fauci said. He blames social media for the misrepresentation of public comments and the spread of misinformation for the overall lack of clarity that many have attributed to his and the CDC’s statements regarding COVID.
Fauci said that if he could go back and do certain things differently, he would. If he had the choice, he would have tried to be much more careful during the early months of the pandemic in underlining the uncertainty of the situation we were going through.
The major shortcoming the U.S. continues to face regarding the pandemic is the resistance to getting vaccinated and ultimately boosted for COVID, Fauci added. And when it comes to vaccines, he doesn’t see the message as polarizing.
“People say [I’m a] polarizing figure,” Fauci said. “Well, when I say we should get vaccinated because it saves lives, and someone says no, am I the polarizing figure? Or is the person who is saying something that’s completely untrue creating the polarization?”
